Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NSE - Delayed Quote INR

Supriya Lifescience Limited (SUPRIYA.NS)

Compare
659.90
+21.55
+(3.38%)
At close: 3:29:46 PM GMT+5:30
Advanced Chart
Loading Chart for SUPRIYA.NS
  • Previous Close 638.35
  • Open 645.95
  • Bid --
  • Ask --
  • Day's Range 640.85 - 662.25
  • 52 Week Range 321.10 - 835.20
  • Volume 245,776
  • Avg. Volume 280,411
  • Market Cap (intraday) 56.203B
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) 30.45
  • EPS (TTM) 21.67
  • Earnings Date --
  • Forward Dividend & Yield 0.80 (0.13%)
  • Ex-Dividend Date Sep 20, 2024
  • 1y Target Est 740.00

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.

www.supriyalifescience.com

448

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Supriya Lifescience Limited

Recent News: SUPRIYA.NS

View More
View More

Performance Overview: SUPRIYA.NS

Trailing total returns as of 3/19/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

SUPRIYA.NS
10.80%
S&P BSE SENSEX (^BSESN)
3.44%

1-Year Return

SUPRIYA.NS
104.13%
S&P BSE SENSEX (^BSESN)
4.77%

3-Year Return

SUPRIYA.NS
42.42%
S&P BSE SENSEX (^BSESN)
30.39%

5-Year Return

SUPRIYA.NS
56.75%
S&P BSE SENSEX (^BSESN)
166.72%

Compare To: SUPRIYA.NS

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

SUPRIYA.NS
Supriya Lifescience Limited
659.90
+3.38%
Mkt Cap INR 56.203B
Industry Biotechnology
BLUEJET.NS
Blue Jet Healthcare Limited
910.85
-1.96%
Mkt Cap INR 165.965B
Industry Biotechnology
ZOTA.NS
Zota Health Care Limited
792.50
-0.08%
Mkt Cap INR 20.484B
Industry Biotechnology
CONCORDBIO.NS
Concord Biotech Limited
1,651.75
+0.02%
Mkt Cap INR 179.164B
Industry Biotechnology
PANACEABIO.NS
Panacea Biotec Limited
431.80
+5.00%
Mkt Cap INR 27.792B
Industry Biotechnology
ASND
Ascendis Pharma A/S
166.05
+0.85%
Mkt Cap 9.978B
Industry Biotechnology
HALO
Halozyme Therapeutics, Inc.
64.30
+2.81%
Mkt Cap 7.919B
Industry Biotechnology
AXSM
Axsome Therapeutics, Inc.
125.90
+0.91%
Mkt Cap 6.14B
Industry Biotechnology
ZEAL.CO
Zealand Pharma A/S
567.50
+1.70%
Mkt Cap DKK 40.094B
Industry Biotechnology
VKTX
Viking Therapeutics, Inc.
30.07
+2.07%
Mkt Cap 3.375B
Industry Biotechnology

Statistics: SUPRIYA.NS

View More

Valuation Measures

As of 3/18/2025

  • Market Cap

    51.27B

  • Enterprise Value

    50.46B

  • Trailing P/E

    27.79

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.37

  • Price/Book (mrq)

    5.35

  • Enterprise Value/Revenue

    7.67

  • Enterprise Value/EBITDA

    19.46

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.02%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.71B

  • Net Income Avi to Common (ttm)

    1.75B

  • Diluted EPS (ttm)

    21.67

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    843.14M

  • Total Debt/Equity (mrq)

    0.61%

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: SUPRIYA.NS

View More
View More

People Also Watch

AMIORG.NS Ami Organics Limited
2,359.50
+4.48%
 
LATENTVIEW.NS Latent View Analytics Limited
372.85
+3.80%
 
TARSONS.NS Tarsons Products Limited
300.35
+4.40%
 
MEDPLUS.NS MedPlus Health Services Limited
708.05
+1.95%
 
TEGA.NS Tega Industries Limited
1,362.30
+0.94%
 
RATEGAIN.NS RateGain Travel Technologies Limited
440.45
-0.91%
 
CMSINFO.NS CMS Info Systems Limited
443.55
+0.66%
 
CLEAN.NS Clean Science and Technology Limited
1,221.90
-0.48%
 
DATAPATTNS.NS Data Patterns (India) Limited
1,714.05
+3.86%
 
JUBLINGREA.NS Jubilant Ingrevia Limited
696.80
+1.40%
 
MAPMYINDIA.NS C. E. Info Systems Limited
1,611.75
+1.31%
 
SIGACHI.NS Sigachi Industries Limited
37.87
+2.21%
 
PARAS.NS Paras Defence and Space Technologies Limited
953.85
+5.47%
 
LXCHEM.NS Laxmi Organic Industries Limited
180.01
+2.60%
 
GOCOLORS.NS Go Fashion (India) Limited
697.95
+2.78%
 
TATVA.NS Tatva Chintan Pharma Chem Limited
675.65
+1.87%